What's new

Human medicines European public assessment report (EPAR): Retsevmo, selpercatinib, Date of authorisation: 11/02/2021, Revision: 16, Status: Authorised

Human medicines European public assessment report (EPAR): Retsevmo, selpercatinib, Date of authorisation: 11/02/2021, Revision: 16, Status: Authorised

Apr 30, 2025 - 12:07
 0
Human medicines European public assessment report (EPAR): Retsevmo, selpercatinib, Date of authorisation: 11/02/2021, Revision: 16, Status: Authorised
Human medicines European public assessment report (EPAR): Retsevmo, selpercatinib, Date of authorisation: 11/02/2021, Revision: 16, Status: Authorised
Read More

Tags:

Previous Article

Vianode dubs synthetic graphite the “e-mobility workhorse”

Next Article

PMQs live: Starmer faces Badenoch after Tony Blair’s criticism of climate strategy

Related Posts

Product Management Service (PMS) information day 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 21 May 2025, 09:00 (CEST) to 21 May 2025, 17:30 (CEST)

Product Management Service (PMS) information day 2025, ...

Apr 29, 2025  0

Human medicines European public assessment report (EPAR): Attrogy, diflunisal, Status: Opinion

Human medicines European public assessment report (EPAR...

Apr 25, 2025  0

Human medicines European public assessment report (EPAR): Eliquis, apixaban, Date of authorisation: 18/05/2011, Revision: 36, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 28, 2025  0